Faculty ProfilesNynikka Palmer, DrPH, MPH
1001 Potrero Ave
San Francisco, CA 94110
Dr. Nynikka Palmer received her undergraduate training from Morgan State University, where she obtained a degree in health education with honors. She then earned a master's degree in public health from Emory University's Rollins School of Public Health and subsequently worked for 3 years at the American Cancer Society in Atlanta, Georgia collaborating with community organizations on cancer education and early detection in minority and underserved communities. Dr. Palmer then earned a doctorate in public health, in behavioral sciences and health promotion from the University of Texas, School of Public Health in Houston. During her doctoral program, she was a pre-doctoral fellow in an NCI-sponsored cancer prevention and control training program. She extended her training in cancer with a focus on cancer survivorship and health disparities as a postdoctoral fellow on an NCI-sponsored training award at Wake Forest School of Medicine. Dr. Palmer was recruited to join the faculty at UCSF in 2013 to further establish her research in cancer health disparities. Currently, she is an Assistant Professor, with a primary appointment in the Division of General Internal Medicine at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFGH) and secondary appointments in Urology and Radiation Oncology. Dr. Palmer is also an Associate member of the UCSF Helen Diller Family Comprehensive Cancer Center and an Associate Faculty member of the Center for Vulnerable Populations at ZSFGH.
Dr. Palmer's research is grounded in cancer disparities and has progressed over the years to focus on racial/ethnic and geographic disparities (e.g., rural/urban) in cancer, challenges faced by male cancer survivors, prostate cancer in African American men, and quality cancer care. During her postdoctoral fellowship, she examined racial/ethnic disparities in health care receipt among male cancer survivors, rural/urban disparities in cancer survivors forgoing care because of cost, and racial/ethnic disparities in patient-provider communication, quality of care ratings, and patient activation among long-term cancer survivors. Dr. Palmer is particularly interested in prostate cancer among African American men, and has examined African American prostate cancer survivors' treatment decision-making and their subsequent quality of life. Findings from these studies have directed her research agenda to further understand and examine quality of care and patient-provider communication among African American men with prostate cancer, particularly in low-income communities. Dr. Palmer's long-term goal is to move beyond identifying cancer disparities to developing, implementing, and disseminating interventions and programs that will ultimately reduce the burden of cancer among vulnerable populations.
Education and Training
|Location||Degree or Training||Specialty||Date|
|University of Texas Health Science Center||DrPH||School of Public Health||2010|
|Emory University||MPH||Rollins School of Public Health||2002|
|Morgan State University||BS||2000|
Cancer disparities, access to and utilization of health care among minority cancer patients, cancer survivorship and follow-up care, dissemination and implementation research, health services and outcomes research, intervention development, patient-provider communication, prostate cancer care, underserved and minority populationsAwards and Honors
Helen Diller Family Chair in Community Education and Outreach for Urologic Cancer, University of California San Francisco, 2016
Distinguished Honoree of the Black Student Health Alliance - 2nd Annual African Heritage Celebration, University of California San Francisco, 2015
Health Disparities Research Loan Repayment Program, National Institute on Minority Health and Health Disparities - National Institutes of Health, 2013-2015
Doctoral Dissertation Research Award, University of Texas Health Science Center at Houston, School of Public Health, 2010
Excellence in Community Outreach, American Cancer Society, 2004
Doctoral Application Support Award, Minority Training Program in Cancer Control Research, Northern California Cancer Center, 2003
Recent Articles (13)
Hiatt RA, Sibley A, Fejerman L, Glantz S, Nguyen T, Pasick R, Palmer N, Perkins A, Potter MB, Somsouk M, Vargas RA, van 't Veer LJ, Ashworth A. The San Francisco Cancer Initiative: A Community Effort To Reduce The Population Burden Of Cancer. Health Aff (Millwood). 2018 Jan; 37(1):54-61.
Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN. Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital. Urol Oncol. 2017 Nov; 35(11):663.e9-663.e14.
Palmer NR, Weaver KE, Hauser SP, Lawrence JA, Talton J, Case LD, Geiger AM. Disparities in barriers to follow-up care between African American and White breast cancer survivors. Support Care Cancer. 2015 Nov; 23(11):3201-9.
Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. Cancer. 2015 Apr 15; 121(8):1265-72.
Palmer NR, Kent EE, Forsythe LP, Arora NK, Rowland JH, Aziz NM, Blanch-Hartigan D, Oakley-Girvan I, Hamilton AS, Weaver KE. Racial and ethnic disparities in patient-provider communication, quality-of-care ratings, and patient activation among long-term cancer survivors. J Clin Oncol. 2014 Dec 20; 32(36):4087-94.
Weaver KE, Palmer N, Lu L, Case LD, Geiger AM. Rural-urban differences in health behaviors and implications for health status among US cancer survivors. Cancer Causes Control. 2013 Aug; 24(8):1481-90.
Palmer NR, Bartholomew LK, McCurdy SA, Basen-Engquist KM, Naik AD. Transitioning from active treatment: colorectal cancer survivors' health promotion goals. Palliat Support Care. 2013 Apr; 11(2):101-9.
Naik AD, Palmer N, Petersen NJ, Street RL, Rao R, Suarez-Almazor M, Haidet P. Comparative effectiveness of goal setting in diabetes mellitus group clinics: randomized clinical trial. Arch Intern Med. 2011 Mar 14; 171(5):453-9.